D-1122-2019 Class III Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-1122-2019 was initiated by AVKARE Inc. on Apr 3, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer) The recall status is terminated (terminated May 7, 2020). Affected quantity: 397 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2019
Initiation Date
Apr 3, 2019
Termination Date
May 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
397 bottles

Product description

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30

Reason for recall

Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)

Distribution pattern

AZ, CO

Code information

Lots: 201916 Exp. 08/2019; 20092 Exp. 08/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1122-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1122-2019. Report a data issue: hello@regdatalab.com.